Clinical implications of p53 alterations in oral cancer progression: a review from India

p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2018
Автори: Patel, K.R., Vajaria, B.N., Singh, R.D., Begum, R., Patel, P.S.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/139242
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-139242
record_format dspace
spelling irk-123456789-1392422018-06-22T16:07:55Z Clinical implications of p53 alterations in oral cancer progression: a review from India Patel, K.R. Vajaria, B.N. Singh, R.D. Begum, R. Patel, P.S. Reviews p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p53, there are alterations in the regulation of the p53. Thus, understanding why p53 is unable to perform its role as a tumor suppressor in these wild-type tumors is very crucial. Germ-line polymorphisms in p53 are also anticipated to cause measurable disturbance in p53 function. Over-expression as well as polymorphic variants of MDM2 might have effects on cancer development. In addition, degradation of p53 by E6 protein of high risk human papillomavirus is also suggested as one of the mechanisms which attenuate p53 responses in oral carcinogenesis. p53 has also been demonstrated to mediate cellular responses upon various DNA damaging cancer therapies, importantly, apoptosis. These responses have been implicated in an individual’s ability to respond to these cancer therapies. Thus, exploring mechanisms by which normal function of p53 is affected in the comprehensive way in oral cancer might aid in the identification of tumor characteristics, prognosis and thus in the development of a new approach to treat the oral cancer. 2018 Article Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/139242 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Reviews
Reviews
spellingShingle Reviews
Reviews
Patel, K.R.
Vajaria, B.N.
Singh, R.D.
Begum, R.
Patel, P.S.
Clinical implications of p53 alterations in oral cancer progression: a review from India
Experimental Oncology
description p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p53, there are alterations in the regulation of the p53. Thus, understanding why p53 is unable to perform its role as a tumor suppressor in these wild-type tumors is very crucial. Germ-line polymorphisms in p53 are also anticipated to cause measurable disturbance in p53 function. Over-expression as well as polymorphic variants of MDM2 might have effects on cancer development. In addition, degradation of p53 by E6 protein of high risk human papillomavirus is also suggested as one of the mechanisms which attenuate p53 responses in oral carcinogenesis. p53 has also been demonstrated to mediate cellular responses upon various DNA damaging cancer therapies, importantly, apoptosis. These responses have been implicated in an individual’s ability to respond to these cancer therapies. Thus, exploring mechanisms by which normal function of p53 is affected in the comprehensive way in oral cancer might aid in the identification of tumor characteristics, prognosis and thus in the development of a new approach to treat the oral cancer.
format Article
author Patel, K.R.
Vajaria, B.N.
Singh, R.D.
Begum, R.
Patel, P.S.
author_facet Patel, K.R.
Vajaria, B.N.
Singh, R.D.
Begum, R.
Patel, P.S.
author_sort Patel, K.R.
title Clinical implications of p53 alterations in oral cancer progression: a review from India
title_short Clinical implications of p53 alterations in oral cancer progression: a review from India
title_full Clinical implications of p53 alterations in oral cancer progression: a review from India
title_fullStr Clinical implications of p53 alterations in oral cancer progression: a review from India
title_full_unstemmed Clinical implications of p53 alterations in oral cancer progression: a review from India
title_sort clinical implications of p53 alterations in oral cancer progression: a review from india
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2018
topic_facet Reviews
url http://dspace.nbuv.gov.ua/handle/123456789/139242
citation_txt Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT patelkr clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia
AT vajariabn clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia
AT singhrd clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia
AT begumr clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia
AT patelps clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia
first_indexed 2023-10-18T21:19:23Z
last_indexed 2023-10-18T21:19:23Z
_version_ 1796152506438385664